| Pharmaceutical active ingredients: |
| Olanzapine |
| Available forms, composition and doses of Olansek: |
| N / A |
| Olansek medical category: |
| Human:Atypical antipsychotics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N05AH03 - Olanzapine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Oktatensin | Guanethidine | Unidentified Pharmaceutical Company |
| Oktatenzin | Guanethidine | Unidentified Pharmaceutical Company |
| Oktedrin | Amphetamine | Unidentified Pharmaceutical Company |
| Okultin M | 2-Methyl-4-Chlorophenoxyacetic Acid | Unidentified Pharmaceutical Company |
| Olamine | Alcohol | Unidentified Pharmaceutical Company |
| Olate Flakes | Sodium Oleate | Unidentified Pharmaceutical Company |
| Oldren | Metolazone | Unidentified Pharmaceutical Company |
| Oleodiazinon | Diazinon | Unidentified Pharmaceutical Company |
| Oleogomenol | Niaouli Oil | Unidentified Pharmaceutical Company |
| Oleovitamin A | Vitamin A | Unidentified Pharmaceutical Company |